Device Trial Radar · NCT06123130
AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection
Last checked: Nov 20, 2026Latest source record: Jul 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
198
Actual
Start
Mar 13, 2024
Primary completion
Jun 20, 2024
Study completion Jun 20, 2024
Sponsor
- Lead sponsor
- HeartBeam, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 8, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a prospective single-arm multicenter clinical trial. Adult patients will be consented and enrolled in an outpatient cardiology office or Arrhythmia Clinics.
Conditions
- Arrhythmias, Cardiac
- Atrial Fibrillation
- Atrial Flutter
- Bradycardia
- Tachycardia
Interventions
Vectorcardiography (VECG)Device
Patients enrolled will undergo diagnostic ECG recording: three sets of simultaneous 30s recordings with the investigational device AIMIGo and a standard 12L ECG.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical equivalence of ECG intervals compared between AIMIGo Synthesized 12L and reference standard 12LTime frame: 30 seconds recording
- Clinical equivalence of ECG amplitudes compared between AIMIGo Synthesized 12L and reference standard 12LTime frame: 30 seconds recording
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Piedmont Heart Institute
Atlanta, Georgia
Atlanta Heart Specialists
Tucker, Georgia
The Mount Sinai Hospital
New York, New York
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.